Connect with us

Health and Wellness

One in six black men will develop prostate cancer, but for some, preventive screenings are a cause for concern

Published

on

Getty Images

News about Secretary of Defense Lloyd Austin’s ‘secret’ hospital stay in January 2024 made waves in the political community. Experts debated the protocol stating that a senior national security official is faraway from duty without the knowledge of the president or the general public, but there was one other factor at play. Secretary Austin received a diagnosis of prostate cancer. “This news shocked me and I know it shocked many others, especially the Black community,” he said of his diagnosis. “It was a punch in the gut.”

One in six black men will develop prostate cancer in their lifetime in comparison with one in eight white men. Black men are 60% more prone to have the disease than white men and a couple of.14 times more prone to die from the disease than white men. Black men also die at higher rates low-grade prostate cancer than other breeds. These rates apply to African-Americans and men of Caribbean descent. Prostate cancer in black men could have biological characteristics related to a more aggressive disease. Research suggests that on account of inherited genetic aspects, differences in cancer biology cause cancer to progress faster in black men and/or be tougher to treat. So what do Black men do to stop this diagnosis? In many cases this just isn’t enough.

Stigmata around séances

Marlon McKnight, a 44-year-old man living in Orlando, has never had a prostate screening and is looking forward to having one. McKnight’s primary care provider told him he needed to schedule an exam sooner or later, but didn’t actually refer him for an exam. When talking about finding a doctor, McKnight recalls growing up in Jamaica, where “we go to the doctor when we’re sick.” He’s taking his time, and McKnight says he’s also sensitive around his rectum and doesn’t want anyone touching him there, irrespective of what. “Just the thought of a man behind me with his fingers inside me makes me nervous,” she admits.

“Black men especially are afraid to take the exam,” he says Brian K. McNeil, MD, MBA, FACS, chief of urology on the University Hospital of Brooklyn. “There is a lot of fear there. Fear of the unknown and fear of the results of the test. McNeil says black men are afraid of getting bad results. Questions are running through their minds, resembling: What will occur if I would like surgery or radiation? Will I actually have problems urinating? Will I actually have to wear a pad or diaper for a very long time?

“Prostate cancer, and prostate health in general, is unique in that it can be linked to masculinity,” McNeil explains. He says some may associate it with feeling like a man, masculinity and sexual function. “Anything that could impact that or impede it in any way becomes a little scary,” he adds.

Professor David B. Miller, Ph.D., MSW, MPH., Case Western Reserve University, says his tests shows that it’s an intersection of possible homophobia, identity and distrust. “So these three factors come into play,” he says. “This doctor is going to stick his finger up my ass. Why is he doing this? There’s something wrong with them. Are they doing this to me for another reason?” Miller claims that every one this mythology and conspiracies are mixed up, after which suddenly he not desires to get tested or see a doctor.

The influence of representation

Jerome Fenton, 40, of Newark, New Jersey, has no qualms about prostate screening. At the age of 30, he developed a colon infection and his doctor really useful a prostate examination at the identical time. He plans to conduct follow-up tests soon. When asked why he feels so good about this process, Fenton replies, “My grandfather died of prostate cancer around 1990. That’s why my mother at all times said, “You’re not too big or too strong to go to the doctor.” ” He said his dad had the identical approach. This is a man who will make an appointment to deal with your concerns, big and small.

Professor Miller says that when black men are raised in an environment where routine medical examinations are normal, they’ve less fear of going to the doctor. Conversely, women find out about gynecological examinations at a young age. For most men, especially black men, before a prostate exam, probably the most invasive exam they experience is a dental exam.

Fenton also believes that many black men hear mostly negative stories about prostate screening and treatment. While they might hear about someone going through treatment and coping with urinary incontinence and erectile dysfunction, they do not hear or see enough about how medications and screenings improve quality of life.

Lack of trust in the medical system can also be a key factor in black men’s reluctance to undergo prostate screening. Several urologists in fact, these are men of color, so the likelihood of somebody with the ability to go to a urologist who looks like them and find a way to discover culturally is low.

Keeping black men alive

The first step to getting tested for black men is to elucidate the method. What is prostate screening? In the past, this involved digital rectal examination (DRE). Your doctor will examine your rectum and examine your prostate for any lumps, lumps, or hardness, in conjunction with a blood test. “A lot of people have done research on whether the blood test itself is OK,” McNeil says. “Although many organizations still recommend using both drugs, some of the latest research shows that a blood test alone may be sufficient.”

There are screening recommendations for different age groups. Some organizations recommend that individuals ages 55 to 70 talk over with their doctor about prostate cancer screening. This is known as collaborative decision-making. You discuss it and choose whether you wish to get tested. Very Urological organizations recommend screening tests aged 50 to 70.

“If you’re in a high-risk group, you might want to have a conversation about screening at age 45,” McNeil says, “and if you’re in a very, very high-risk group, you might want to consider having that conversation at age 40.”

McNeil says your risk level is set by your age and whether you’ve gotten a member of the family who has been diagnosed with prostate cancer, resembling a father, uncle, brother or cousin. “The age at which a person is diagnosed with prostate cancer matters,” he says. “You want to consider whether your relative died from complications related to prostate cancer.” Perhaps you’ve gotten a relative who was diagnosed with prostate cancer and it was a low-grade cancer who was treated, recovered, and lived a long life. But if you happen to are a member of the family who was diagnosed with prostate cancer and died that very same 12 months, it’s a completely different situation.

Studies have shown that certain genes related to other gynecological cancers could also be related to a higher risk of prostate cancer in men. Especially, BRCA one and two are related to an increased risk of prostate cancer. It is important to know your loved ones’s medical history, each in your father’s and mother’s sides.

“I discovered that this needed to be explained to black men, why they were at higher risk and the way vital it was to get this checked. It’s about explaining what which means so that they could make an informed decision,” Miller says.

And if it helps to simplify things, McNeil wants black men to keep in mind that, identical to a automotive, their body requires maintenance. Consider your urologist as a part of that maintenance. Good prostate health ensures higher peeing, uninterrupted sleep, and a satisfying sex life. And yes, it will probably keep them alive. “It’s not just about the finger,” McNeil says. “It’s about helping save lives.”

This article was originally published on : www.essence.com
Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health and Wellness

Jury awarded $310 million to parents of teenager who died after falling on a ride at Florida amusement park – Essence

Published

on

By

Sun Sentinel/Getty Images

The family of Tire Sampson, the 14-yr-old who tragically died on an amusement park ride in Orlando, Florida, in 2022, has been awarded $310 million in a civil lawsuit.

Tire, who was visiting ICON Park along with his family on March 24, 2022, fell from the FreeFall drop tower. Although he was taken to a nearby hospital, he didn’t survive his injuries.

Now, greater than two years later, a jury has held the vehicle manufacturer, Austria-based Funtime Handels, responsible for the accident and awarded the Tire family $310 million. According to reports from local news stations WFTV AND KSDKthe jury reached its verdict after about an hour of deliberation.

Tyre’s parents will each receive $155 million, according to attorney spokesman Michael Haggard.

Attorneys Ben Crump and Natalie Jackson, who represented Tyre’s family, shared their thoughts on this landmark decision via X (formerly Twitter). “This ruling is a step forward in holding corporations accountable for the safety of their products,” they said in a statement.

Lawyers stressed that Tyre’s death was attributable to “gross negligence and a failure to put safety before profits.” They added that the ride’s manufacturer had “neglected its duty to protect passengers” and that the substantial award ensured it could “face the consequences of its decisions.”

Crump and Jackson said they hope the result will encourage change throughout the theme park industry. “We hope this will spur the entire industry to enforce more stringent safety measures,” they said. “Tire heritage will provide a safer future for drivers around the world.”

An investigation previously found that Tyre’s harness was locked through the descent, but he dislodged from his seat through the 430-foot fall when the magnets engaged. Tire’s death was ruled the result of “multiple injuries and trauma.”

ICON Park said at the time that it could “fully cooperate” with the authorities.

This article was originally published on : www.essence.com
Continue Reading

Health and Wellness

Tireless HIV/AIDS advocate A. Cornelius Baker dies

Published

on

By

HIV/AIDS Advocate, A. Cornelius Baker


A. Cornelius Baker, a tireless advocate of HIV and AIDS testing, research and vaccination, died Nov. 8 at his home in Washington, D.C., of hypertensive, atherosclerotic heart problems, in response to his partner, Gregory Nevins.

As previously reported, Baker was an early supporter for people living with HIV and AIDS within the Nineteen Eighties, when misinformation and fear-mongering in regards to the disease were rampant.

According to Douglas M. Brooks, director of the Office of National AIDS Policy under President Obama, it was Baker’s Christian faith that guided him toward compassion for others.

“He was very kind, very warm and inclusive – his circles, both professional and personal, were the most diverse I have ever seen, and he was guided by his Christian values,” Brooks told the outlet. “His ferocity was on display when people were marginalized, rejected or forgotten.”

In 1995, when he was executive director of the National AIDS Association, Baker pushed for June 27 to be designated National HIV Testing Day.

In 2012, he later wrote on the web site of the Global Health Advisor for which he was a technical advisor that: “These efforts were intended to help reduce the stigma associated with HIV testing and normalize it as part of regular screening.”

https://twitter.com/NBJContheMove/status/1856725113967632663?s=19

Baker also feared that men like himself, black gay men, and other men from marginalized communities were disproportionately affected by HIV and AIDS.

Baker pressured the Clinton administration to incorporate black and Latino people in clinical drug trials, and in 1994 he pointedly told the Clinton administration that he was bored with hearing guarantees but seeing no motion.

According to Lambda Legal CEO Kevin Jennings, yes that daring attitude that defines Baker’s legacy in the world of ​​HIV/AIDS promotion.

“Cornelius was a legendary leader in the fight for equality for LGBTQ+ people and all people living with HIV,” Jennings said in a press release. “In the more than twenty years that I knew him, I was continually impressed not only by how effective he was as a leader, but also by how he managed to strike the balance between being fierce and kind at the same time. His loss is devastating.”

Jennings continued: “Cornelius’ leadership can’t be overstated. For many years, he was one in all the nation’s leading HIV/AIDS warriors, working locally, nationally and internationally. No matter where he went, he proudly supported the HIV/AIDS community from the Nineteen Eighties until his death, serving in various positions including the Department of Health and Human Services, the National Association of Persons with Disabilities AIDS, and the Whitman-Walker Clinic . Jennings explained.

Jennings concluded: “His career also included several honors, including being the first recipient of the American Foundation for AIDS Research Foundation’s organization-building Courage Award. Our communities have lost a pillar in Cornelius, and as we mourn his death, we will be forever grateful for his decades of service to the community.”

Kaye Hayes, deputy assistant secretary for communicable diseases and director of the Office of Infectious Diseases and HIV/AIDS Policy, in her comment about his legacy, she called Baker “the North Star.”.

“It is difficult to overstate the impact his loss had on public health, the HIV/AIDS community or the place he held in my heart personally,” Hayes told Hiv.gov. “He was pushing us, charging us, pulling us, pushing us. With his unwavering commitment to the HIV movement, he represented the north star, constructing coalitions across sectors and dealing with leaders across the political spectrum to deal with health disparities and advocate for access to HIV treatment and look after all. He said, “The work isn’t done, the charge is still there, move on – you know what you have to do.” It’s in my ear and in my heart in the case of this job.

Hayes added: “His death is a significant loss to the public health community and to the many others who benefited from Cornelius’ vigilance. His legacy will continue to inspire and motivate us all.”

Baker is survived by his mother, Shirley Baker; his partner Nevins, who can be senior counsel at Lambda Legal; his sisters Chandrika Baker, Nadine Wallace and Yavodka Bishop; in addition to his two brothers, Kareem and Roosevelt Dowdell; along with the larger HIV/AIDS advocacy community.


This article was originally published on : www.blackenterprise.com
Continue Reading

Health and Wellness

Bovaer is added to cow feed to reduce methane emissions. Does it pass into milk and meat? And is it harmful to humans?

Published

on

By

There are growing concerns in regards to the use of feed supplements, Bowar 10to reduce methane production in cows.

Bovaer 10 consists of silicon dioxide (mainly sand), propylene glycol (food stabilizer approved by Food Safety Australia New Zealand) and lively substance 3-nitrooxypropanol (3-NOP).

There has been an enormous amount of misinformation in regards to the safety of 3-NOP, with some milk from herds fed this additive being labeled “Frankenmilk”. Others feared it could get to humans through beef.

The most significant thing is that 3-NOP is secure. Let’s clear up some major misconceptions.

Why do we want to limit methane production?

In our attempts to limit global warming, we’ve placed the best emphasis on CO₂ because the major man-made greenhouse gas. But methane is also a greenhouse gas, and although we produce less of it, it is: a much stronger greenhouse gas than CO₂.

Agriculture is the largest a man-made source of methane. As cattle herds expand to meet our growing demand for meat and milk, reducing methane production from cows is a vital way to reduce greenhouse gas emissions.

There are several ways to do that. Stopping bacteria within the stomachs of cows that produce methane one approach is to produce methane.

The methane produced by cows and sheep doesn’t come from the animals themselves, but from the microbes living of their digestive systems. 3-NO stop the enzymes that perform the last step of methane synthesis in these microorganisms.

3-NOP is not the one compound tested as a feed additive. Australian product based on seaweed, Rumin8for instance, it is also in development. Saponins, soap-like chemicals present in plants, and essential oils as well has been examined.

However, 3-NOP is currently one of the popular effective treatments.

Nitrooxypropanol structure: red balls are oxygen, gray carbon, blue nitrogen and white hydrogen.
PubChem

But is not it poison?

There are concerns on social media that Bovaer is “poisoning our food.”

But, as we are saying in toxicology, it’s the dose that makes the poison. For example, arsenic is deadly 2–20 milligrams per kilogram of body weight.

In contrast, 3-NOP was not lethal on the doses utilized in safety studies, up to 600 mg 3-NOP per kg body weight. At a dose of 100 mg per kg body weight in rats, it didn’t cause any adversarial effects.

What about reproductive issues?

The effect of 3-NOP on the reproductive organs has generated numerous commentary.

Studies in rats and cows showed that doses of 300–500 mg per kg body weight caused: contraction of the ovaries and testicles.

In comparison, to achieve the identical exposure in humans, a 70 kg human would want to eat 21–35 grams (about 2 tablespoons) of pure 3-NOP every day for a lot of weeks to see this effect.

No human will likely be exposed to this amount because 3-NOP doesn’t pass into milk – is fully metabolized within the cow’s intestines.

No cow will likely be exposed to these levels either.

The cow licks itself
Cows will not be exposed to levels tested on animals in laboratory studies.
Ground photo/Shutterstock

What about cancer?

3-NOP is not genotoxic or mutagenicwhich implies it cannot damage DNA. Thus, the results of 3-NOP are dose-limited, meaning that small doses will not be harmful, while very high doses are (unlike radiation where there is no secure dose).

Scientists found that at a dose of 300 mg per kilogram of body weight benign tumors of the small intestine of female ratsbut not male rats, after 2 years of every day consumption. At a dose of 100 mg 3-NOP per kg body weight, no tumors were observed.

Cows eat lower than 2 grams of Bovaer 10 per day (of which only 10% or 0.2 grams is 3-NOP). This is about 1,000 times lower than the appropriate every day intake 1 mg 3-NOP per kg body weight per day for a cow weighing 450 kg.

This level of consumption will likely be not the result in cancer or any of them other adversarial effects.

So how much are people exposed to?

Milk and meat consumers will likely be exposed to zero 3-NOP. 3-NOP doesn’t penetrate milk and meat: is completely metabolized within the cow’s intestines.

Farmers could also be exposed to small amounts of the feed additive, and industrial employees producing 3-NOP will potentially be exposed to larger amounts. Farmers and industrial employees already wear personal protective equipment to reduce exposure to other agricultural chemicals – and it is advisable to do that with Bovear 10 as well.

Milk
3-NOP doesn’t penetrate milk and meat.
Shutterstock

How widely has it been tested?

3-NOP has been in development for 15 years and has been subject to multiple reviews by European Food Safety Authority, UK Food Safety Authority AND others.

It has been extensively tested over months of exposure to cattle and has produced no unintended effects. Some studies actually say so improves the standard of milk and meat.

Bovaer was approved for use in dairy cattle by the European Union from 2022 and Japan in 2024. It is also utilized in many other countries, including: in beef products, amongst others Australia.

A really small amount of 3-NOP enters the environment (lower than 0.2% of the dose taken), no accumulates and is easily decomposed subsequently, it doesn’t pose a threat to the environment.

Since humans will not be exposed to 3-NOP through milk and meat, long-term exposure is not an issue.

What does Bill Gates have to do with this?

Bill Gates has invested in a distinct feed processing method for methane, Australian seaweed-based Rumin8. But he has nothing to do with Bovaer 10.

The Bill & Melinda Gates Foundation awarded research grants to the corporate producing 3-NOP for malaria control researchnot for 3-NOP.

The bottom line is that adding 3-NOP to animal feed doesn’t pose any risk to consumers, animals or the environment.

This article was originally published on : theconversation.com
Continue Reading
Advertisement

OUR NEWSLETTER

Subscribe Us To Receive Our Latest News Directly In Your Inbox!

We don’t spam! Read our privacy policy for more info.

Trending